Risks and benefits of importing prescription medications from lower-income countries.
作者信息
Dhalla Irfan A, Detsky Allan S
机构信息
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
出版信息
JAMA. 2008 Sep 24;300(12):1453-5. doi: 10.1001/jama.300.12.1453.
PMID:18812537
Abstract
摘要
相似文献
1
Risks and benefits of importing prescription medications from lower-income countries.
JAMA. 2008 Sep 24;300(12):1453-5. doi: 10.1001/jama.300.12.1453.
2
Where does drug importation stand now?
Med Econ. 2005 Mar 18;82(6):42, 44, 46.
3
A perspective on US drug reimportation.
JAMA. 2005 Jan 19;293(3):358-62. doi: 10.1001/jama.293.3.358.
4
Why are we Being Overcharged for Pharmaceuticals? What Should We Do About It?
J Leg Med. 2019 Apr-Jun;39(2):137-149. doi: 10.1080/01947648.2019.1645542.
5
Seizures of Canadian drugs rise as Congress, Customs spar.
Wall St J (East Ed). 2006 Jul 24:B1, B8.
6
Pharmaceuticals and medical devices: business practices.
Issue Brief Health Policy Track Serv. 2012 Jan 3:1-35.
7
FDA recognition of first-world drug regulators as means of relieving U.S. drug shortages.
Am J Health Syst Pharm. 2012 Oct 1;69(19):1626, 1628. doi: 10.2146/ajhp120478.
8
Pharmaceuticals and medical devices: business practices. Issue brief.
Issue Brief Health Policy Track Serv. 2012 Dec 31:1-36.
9
Imported prescription drugs are not the answer.
Manag Care. 2004 Mar;13(3 Suppl):38-40.
Zotero 插件